Joaquín Casal‐Rubio

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · The Lancet Oncology · 2020 · 828 citations

Medicine, Oncology, Pharmacology +14

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

Mariano Provencio, Ernest Nadal, J.L. González-Larriba et al. · New England Journal of Medicine · 2023 · 450 citations · Full text

Medicine, Oncology, Surgery +17

Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)

Mariano Provencio, Enric Carcereny, Delvys Rodríguez‐Abreu et al. · Translational Lung Cancer Research · 2019 · 93 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14

Lung cancer symptoms at diagnosis: results of a nationwide registry study

Alberto Ruano‐Raviña, Enric Carcereny, Teresa Morán et al. · ESMO Open · 2020 · 78 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy

Juan Ruiz‐Bañobre, María C. Areses-Manrique, Joaquín Mosquera et al. · Translational Lung Cancer Research · 2019 · 62 citations · Full text

Medicine, Immunology, Oncology +17